Why the study?
Despite advances in pharmacology and interventional treatments, atrial fibrillation poses risks of severe complications and still cannot be completely eliminated in patients.
Answers are grounded in this paper and cite their sources.
This historical review highlights the evolution of atrial fibrillation management, emphasizing the shift towards individualized strategies combining innovative non-pharmacological technologies with antiarrhythmic drugs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Кanorskiy et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: